A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer

Clinical trial NCT00607607 · COMPLETED

Trial details

NCT number: NCT00607607
Sponsor: CASI pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Endometrial Cancer

Start date: 2008-01-01
Primary completion: 2011-06-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.